An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases

Overview of attention for article published in Frontiers in immunology, November 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 35 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC FCRN

Application WO-2022166900-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.